Cancer is a major concern in the world with an average of four deaths. Cervical cancer is the fourth most common cancer among women, and the seventh overall, with an estimated 528 000 new cases in 2012. As with liver cancer, a large majority (around 85%) of the global burden occurs in the less developed regions, where it accounts for almost 12% of all female cancers. High-risk regions, with estimated ASRs over 30 per 100 000, include Eastern Africa (42.7), Melanesia (33.3), and Southern (31.5), and Middle (30.6) Africa. Rates are the lowest in Australia/New Zealand (5.5) and Western Asia (4.4). Cervical cancer remains the most common cancer among women in Eastern and Middle Africa. There were an estimated 266 000 deaths from cervical cancer worldwide in 2012, accounting for 7.5% of all female cancer deaths. Almost 9 out of 10 (87%) cervical cancer deaths occur in the less developed regions. Mortality varies 18-fold among the different regions of the world with the rates ranging from less than 2 per 100 000 in Western Asia, Western Europe, and Australia/New Zealand to more than 20 per 100 000 in Melanesia (20.6), Middle (22.2), and Eastern (27.6) Africa (
1,
2).
The results of research till 2010 show cervical cancer as one of the causes of death among women over 15 years old. Besides, the statistical results of this study show a drastic increase in the prevalence of this cancer (
3). Researchers at the University of Manchester have reported a 40% increase in the prevalence of cervical cancer in young women in recent decades (
4). Researchers in Eastern Europe have also found alarming signs of an increase in the disease in the Baltics, Romania, and Bulgaria (
5). Cervical cancer is the most prevalent one in India (
6). The frequency of this cancer in Iran is relatively less than that of other countries. According to the National Cancer Registry report of 2009, the prevalence of cervical cancer in Iran was 2.17 per 100 000 people and ranked 11th among cancers in Iranian females with a slight increase compared to the 2008 report (
7). According to the statistics reported in 2017, the crude incidence rate of cervical cancer among women was 2.5, 1.7, and 15.1 cases per 100 000 in Iran, South Asia, and the world, respectively. Also, the crude death rate for cervical cancer was 1, 9.4, and 7.6 women per 100 000 in Iran, South Asia, and the world, respectively (
8).
Survival analysis, as one of the most important statistical methods in analyzing data collected over time, attracted the attention of many statisticians (
9-
11). In the usual methods of survival analysis, it is assumed that all individuals in the population under study are susceptible to the aimed event, while there are times when some people in the community are immune to the incident and do not experience it until the end of their life. These individuals are referred to as "safe or improved" groups. Therefore, in this case, the basic assumption of the usual methods of survival analysis is abandoned. To study such a population, which consists of 2 susceptible and safe subgroups, survival analysis methods known as healing models should be used.
In such studies, particularly in cancer research, cure models are used to analyze the data regarding the time till the occurrence of an event, from which a portion of the population is safe. Members of the long-term survival group are those, who are immune to the event. It is worth noting that, in the case of the non-existence of safe people, the models presented in the mixture cure model can turn back to the standard survival models (
12-
14). These models can be either parametric or nonparametric. The main goal in the cured mixture models is to estimate the proportion of cured or safe individuals (who do not experience the desired event at all), the survival function for those exposed to the event (the susceptible individuals), and the factors affecting these two cases (
12,
13). In such a model, the probability of being cured can only be gained through maximum likelihood estimation; in other words, the safety of individuals cannot be determined (
13,
14).
Due to the random pattern of censored data, it is not easy to differentiate the safe people from the censored data because censored observations result from excluding people from the study, missing or losing information, or insufficient time to follow up a study due to ethical or financial limitations. In case the cured individuals exist in the population under study, they have a relatively long survival time; in other words, these individuals will not be affected by the aimed event till the end of the study. So, these people are those who have a long censorship time (
13).
One of the presuppositions in Cox's proportional risk model is that all individuals in the study will experience the aimed event until the end of the study (
15). However, sometimes a significant proportion of individuals do not experience the event during the follow-up period. In incurable chronic diseases that maintain their progression, all the patients will gradually die. Though, sometimes things are different. For example, all those who are infected by HIV, are not affected by it; this means that a percentage of the individuals are safe. In such cases, the Cox risk model will not be appropriate because one of its main presumptions is rejected. Therefore, the cure models must be used here as they do not need a certain presumption (
13).
In the survival analysis, when mortality reaches the maximum and, then, gradually decreases after a finite period, it is better to use models, which have a non-uniform failure rate, e.g. log-logistic and log-normal models (
16,
17). In the present study, the risk function has such a pattern; that is, it increases at first and, then, decreases after a while. Thus, using Cox-Weibull and exponential models will not be the right choice as the log-logistic and log-normal models can better estimate the data.